| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Mogamulizumab-kpkc (Poteligeo) | 2024-07-15 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Edaravone (Radicava) | 2024-07-15 |
| BCBS Highmark Penn Medicare Advantage | Mogamulizumab-kpkc (Poteligeo) | 2024-07-15 |
| BCBS Highmark Penn Medicare Advantage | Edaravone (Radicava) | 2024-07-15 |
| BCBS Highmark NY and West NY | Mogamulizumab-kpkc (Poteligeo) | 2024-07-15 |
| BCBS Highmark NY and West NY | Edaravone (Radicava) | 2024-07-15 |
| BCBS Highmark Delaware | Mogamulizumab-kpkc (Poteligeo) | 2024-07-15 |
| BCBS Highmark Delaware | Edaravone (Radicava) | 2024-07-15 |
| BCBS Highmark West Virginia | Autologous Cellular Immunotherapy for Prostate Cancer | 2024-07-15 |
| BCBS Highmark West Virginia | Edaravone (Radicava) | 2024-07-15 |